Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7


Controlled and cardiac-restricted overexpression of the arginine vasopressin V1A receptor causes reversible left ventricular dysfunction through Gαq-mediated cell signaling.

Li X, Chan TO, Myers V, Chowdhury I, Zhang XQ, Song J, Zhang J, Andrel J, Funakoshi H, Robbins J, Koch WJ, Hyslop T, Cheung JY, Feldman AM.

Circulation. 2011 Aug 2;124(5):572-81. doi: 10.1161/CIRCULATIONAHA.111.021352. Epub 2011 Jul 11.


Adenosine receptor subtypes and the heart failure phenotype: translating lessons from mice to man.

Feldman AM, Cheksis-Feiner E, Hamad E, Chan T.

Trans Am Clin Climatol Assoc. 2011;122:198-214. Review.


Vasopressin V1a and V1b receptors: from molecules to physiological systems.

Koshimizu TA, Nakamura K, Egashira N, Hiroyama M, Nonoguchi H, Tanoue A.

Physiol Rev. 2012 Oct;92(4):1813-64. doi: 10.1152/physrev.00035.2011. Review.


The roles of V1a vasopressin receptors in blood pressure homeostasis: a review of studies on V1a receptor knockout mice.

Fujiwara Y, Tanoue A, Tsujimoto G, Koshimizu TA.

Clin Exp Nephrol. 2012 Feb;16(1):30-4. doi: 10.1007/s10157-011-0497-y. Epub 2011 Nov 1. Review.


Arginine vasopressin receptor signaling and functional outcomes in heart failure.

Wasilewski MA, Myers VD, Recchia FA, Feldman AM, Tilley DG.

Cell Signal. 2016 Mar;28(3):224-233. doi: 10.1016/j.cellsig.2015.07.021. Epub 2015 Jul 30. Review. No abstract available.


Are transgenic mice the 'alkahest' to understanding myocardial hypertrophy and failure?

Cook SA, Clerk A, Sugden PH.

J Mol Cell Cardiol. 2009 Feb;46(2):118-29. doi: 10.1016/j.yjmcc.2008.11.005. Epub 2008 Nov 21. Review.


Supplemental Content

Support Center